Cost effectiveness of immune checkpoint inhibitors in NSCLC according to PD-L1 expression.

被引：3

作者：

Aguiar, Pedro Nazareth

Tadokoro, Hakaru

Barreto, Carmelia Maria Noia

Santoro, Ilka Lopes

De Mello, Ramon Andrade

Babiker, Hani M.

Avancha, Kiran

Lopes, Gilberto

机构：

[1] Univ Fed Sao Paulo, Sao Paulo, Brazil

[2] Univ Algarve, Dept Biomed Sci & Med, Faro Med Oncol & Res Ctr, Faro, Portugal

[3] HonorHlth Res Inst, Virginia G Piper Canc Ctr Clin Trials, Scottsdale, AZ USA

[4] HonorHlth Res Inst, Scottsdale, AZ USA

[5] Inst Canc Estado Sao Paulo, Clin Oncol, Sao Paulo, Brazil

来源：

关键词：

D O I：

10.1200/JCO.2016.34.15_suppl.9033

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

9033

引用

页数：3